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Abstract  
Background: Improving Access to Psychological Therapy (IAPT) services treat most 
patients in England who present to primary care with major depression. Psychodynamic 
psychotherapy is one of the psychotherapies offered. Dynamic Interpersonal Therapy (DIT), 
is a psychodynamic and mentalization-based treatment for depression. 16 sessions are 
delivered over approximately 5 months. Neither DIT’s effectiveness relative to low-intensity 
treatment (LIT), nor the feasibility of randomizing patients to psychodynamic or cognitive-
behavioural treatments (CBT) in an IAPT setting, has been demonstrated. 
Methods: 147 patients were randomized in a 3:2:1 ratio to DIT (n = 73), LIT (control 
intervention; n = 54) or CBT (n = 20) in four IAPT treatment services in a combined 
superiority and feasibility design. Patients meeting criteria for major depressive disorder were 
assessed at baseline, mid-treatment (3 months) and post-treatment (6 months) using the 
Hamilton Rating Scale for Depression (HRSD-17), Beck Depression Inventory-II (BDI-II) 
and other self-rated questionnaire measures. Patients receiving DIT were also followed up 6 
months post-completion. 
Results: The DIT arm showed significantly lower HRSD-17 scores at the 6-month primary 
end-point compared with LIT (d = 0.70). Significantly more DIT patients (51%) showed 
clinically significant change on the HRSD-17 compared with LIT (9%). The DIT and CBT 
arms showed equivalence on most outcomes. Results were similar with the BDI-II. DIT 
showed benefit across a range of secondary outcomes. 
Conclusions: DIT delivered in a primary care setting is superior to LIT and can be 
appropriately compared with CBT in future RCTs.  
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Introduction 
Depressive disorders constitute a major global health problem (World Health Organization 
2001; Lopez et al. 2006). Psychosocial treatments are as effective as medication (National 
Institute for Health and Clinical Excellence 2009; Spielmans et al. 2011; Cuijpers et al. 2013) 
and are often preferred by clients (Zimmerman et al. 2008; McHugh et al. 2013; Hanson et 
al. 2016). Cognitive-behavioural therapy (CBT) has a large evidence base, including data on 
cost-effectiveness (Cuijpers et al. 2013; The Community Mental Health Team 2016). 
Interpersonal psychotherapy (IPT), a brief psychotherapy addressing interpersonal problems 
of individuals with depression, has a smaller evidence base (Lemmens et al. 2015). Longer-
term recovery is not guaranteed even by CBT or IPT (the ‘best’ evidence-based treatments) 
(Hollon et al. 2006; Karyotaki et al. 2016; The Community Mental Health Team 2016). 
Choice of therapy is important because no single modality has been firmly established as 
superior (Cuijpers et al. 2008; Cuijpers et al. 2011; Cuijpers et al. 2013; Cuijpers et al. 2014). 
Several randomized controlled trials (RCTs) have examined the effectiveness of 
psychodynamic psychotherapy for depression. Evidence for its efficacy is accumulating 
(Fonagy 2015; Leichsenring et al. 2015). Meta-analytic findings reveal large pre–post 
treatment effects, with results maintained at long-term follow-up (Driessen et al. 2010; 
Abbass et al. 2014; Driessen et al. 2015). PDT has been shown to be non-inferior to other 
active treatments, including cognitive therapy (Driessen et al. 2015; Connolly Gibbons et al. 
2016; Steinert et al. 2017). The National Institute for Health and Care Excellence (NICE) 
(2017) identifies short-term psychodynamic psychotherapy (STPP) as an option for people 
who have declined CBT and IPT, but there are several implementations. 
Some UK providers have adopted Dynamic Interpersonal Therapy (DIT; Lemma et 
al. 2010, 2011) as a ‘prototype’ of STPP. DIT’s structured framework enables therapists 
without extensive training in psychodynamic psychotherapy to practise. DIT is a time-limited 
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16-session treatment that formulates the presenting symptoms of depression as responses to 
interpersonal difficulties or perceived threats to attachments. It is therefore particularly well 
suited to implementation in a primary-care, community-based context. 
The Improving Access to Psychological Therapies (IAPT) programme in England is 
an internationally unique implementation of evidence-based psychological therapies for 
common mental disorders in the community (Clark et al. 2017). It provides a number of 
evidence-based treatments for depressive disorders (the most common problem for which 
psychological therapy is offered (Perfect et al. 2016)). In line with guidelines from NICE 
(2017), CBT is currently offered to most patients presenting with depression in IAPT 
services; DIT is offered in relatively few services. IAPT is committed to improving access to 
and widening the choice of psychological therapies (Guy et al. 2012). Therefore, evidence for 
the effectiveness of alternative treatments is crucial. DIT’s effectiveness as a STPP for 
patients with depression within community services has not yet been established. The REDIT 
(Randomized Evaluation of Dynamic Interpersonal Therapy) study aimed to (i) evaluate 
DIT’s effectiveness for moderate to severe depression in adults within IAPT, comparing the 
outcomes associated with DIT with a low-intensity treatment (LIT) condition, and (ii) 
evaluate the feasibility of comparing the treatment of adult depression with DIT and CBT 
within IAPT services.  
 
Method 
Trial design 
The trial was conducted within IAPT services, which are based on a stepped-care model, 
where patients recognized as depressed in primary care or hospital settings (Step 1) are 
offered triage or low-intensity (Step 2) or high-intensity (Step 3) treatment, depending on 
clinical need. Triage followed the IAPT protocol and focused on evaluating severity and 
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suicide/self-harm risk. Low-intensity treatment (LIT), delivered by a Psychological 
Wellbeing Practitioner (PWP), involves guided self-help. High-intensity treatment typically 
involves face-to-face treatment, such as CBT, with an accredited therapist. Participants were 
recruited from four sites: two for the DIT v. LIT comparison, and two separate sites for the 
DIT v. CBT comparison. Participants in the low-intensity condition who had not recovered 
were offered high-intensity therapy after completing 4–6 months of guided self-help 
treatment. In parallel, at two IAPT sites, patients were randomized to either DIT or CBT. The 
trial was granted ethical approval by NHS Research Ethics Committees and was registered 
with the ISRCTRN Registry (ISTCRN38209986; ISTCRN06629587).  
 
Sample size calculation  
Recruitment was powered for a superiority trial of DIT v. LIT. An a priori power analysis 
suggested that a sample size of 54 (27 in each group) was required to detect a mean 
difference of 5 (SD = 5.62) on the Hamilton Rating Scale for Depression (HRSD) at 90% 
power and a 5% type I error rate. The study was thus well powered to detect superiority in the 
DIT v. LIT comparison (nDIT = 48 and nLIT = 31 at 6 months). There was no intention to 
incorporate a CBT v. LIT comparison (nCBT = 15 at 6 months) because the CBT arm was 
included only to assess the feasibility of comparing DIT and CBT1. We report on results 
obtained from CBT without comment other than in relation to the acceptability, attrition, and 
timing of assessments for the sake of comprehensiveness. 
 
Participants 
Recruitment took place from November 2012 to January 2015. Patients consecutively 
                                                 
1 A formal test of equivalence between DIT and CBT groups will require 205 patients in each group, based on a 
Type I error rate of 5%, 90% power, an equivalence limit of 2 on the HRSD, and a population standard 
deviation of 5.62 (the mean of 52 standard deviations of post-CBT HRSD scores; Cuijpers et al. 2010). 
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referred to four metropolitan IAPT sites, aged 18 and above, who met DSM-IV criteria for a 
major depressive episode (American Psychiatric Association 1994) established by research 
staff using the MINI Plus 6.0 interview (Sheehan et al. 1998), scored >14 on the HRSD and 
>10 on the Patient Health Questionnaire (PHQ-9) (Kroenke et al. 2001), and were identified 
as likely to require high-intensity treatment after triage, were approached to participate. As in 
most instances there would be significant delay in implementing high-intensity treatments, 
the referral to a low-intensity treatment with the offer of high-intensity treatment to follow if 
required was considered ethically acceptable. Exclusion criteria were current psychotic 
symptoms or bipolar disorder, clinical contraindications for short-term psychotherapy 
including current use of antipsychotic medication, historical clinical diagnosis of Axis II 
disorder, historical or current repeated non-suicidal self-injury, disclosure of current suicidal 
intent and plans, historical or current eating disorder, and historical or current substance 
abuse. Furthermore, non-English speakers, those who had participated in another clinical trial 
within the past year in which they had received CBT or STPP for depression, those who had 
had previous unsuccessful CBT, and those with highly unstable or insecure life arrangements 
were excluded from the trial. Figure 1 shows recruitment to the trial. 
 
Assessments 
Clinicians at recruiting IAPT sites referred suitable patients to the trial team. Referred 
patients were given a baseline assessment by a research assistant to assess eligibility. This 
included structured clinical interviews and self-report measures. Participants were followed 
up mid-treatment (3 months; approximately 90 days) and after the end of treatment (6 
months; approximately 180 days). Those in the DIT arm were followed up on average 12 
months (approximately 360 days) post-randomization to establish whether treatment gains 
were maintained.  
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Randomization  
Participant randomization was undertaken by an administrator independent of the trial, based 
at a different location from the research team and blind to the hypotheses or trial conditions. 
Following the completion of a baseline assessment by the research team, minimization 
criteria (including sex, severity of depression and age) were e-mailed with the request for 
randomization. Depending on the site at which they were recruited, participants were 
randomized to either the DIT or LIT condition, or the DIT or CBT condition, using a 
minimization algorithm with an 80% bias to minimize imbalance in a ratio of 3:2:1 for the 
three treatment groups.  
 
Interventions 
Dynamic Interpersonal Therapy. DIT is a brief dynamically oriented intervention informed 
by attachment and mentalization theory (Lemma et al. 2010, 2011; Luyten and Blatt 2012) 
which owes much to conceptualizations of dynamic therapy advanced by Luborsky and Crits-
Christoph (1998) and Kernberg (1988). It views symptoms of depression and anxiety as 
responses to interpersonal difficulties or perceived threats to attachments (loss/separation) 
and hence also as threats to the self. DIT aims to help patients improve their ability to cope 
with current attachment-related interpersonal challenges through better understanding their 
subjective reactions to them as threats, making implicit anxieties and concerns explicit, and 
improving their ability to reflect on their own and others’ thoughts and feelings. DIT helps 
patients understand the connection between their presenting symptoms and their relationships 
by identifying a core, non-conscious, repetitive pattern of relating. This pattern, termed the 
interpersonal affective focus, becomes the therapy’s central focus, and the therapist works on 
the conscious cost of such repetitive patterns. DIT primarily targets the assumed dynamic 
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origins of depressive symptoms and, secondarily, enhanced interpersonal functioning through 
improved capacity to reflect on the individual’s own states of mind as well as those of others.  
DIT was delivered within IAPT services by trained DIT practitioners with an 
approved DIT supervisor. Participants were offered 16 weekly sessions, each lasting 
approximately 1 hour.  
 
Low-intensity treatment. LIT had a comparable time span to DIT. It consisted of fortnightly 
individual sessions with a PWP using a self-guided manual-based programme commonly 
used in IAPT services (Coull and Morris 2011). The LIT condition was designed to reflect 
interventions usually offered at Step 2 within IAPT services, including guided self-help, 
psychoeducation, and face-to-face and telephone support using NICE-recommended 
interventions. The maximum number of sessions offered was nine. After the 16–24-week LIT 
period, all participants who had not recovered were offered high-intensity therapy (CBT, IPT, 
counselling or DIT). 
 
Cognitive-behavioural therapy. CBT was delivered within IAPT services by trained CBT 
practitioners under supervision following the standard IAPT high-intensity protocol (Roth 
and Pilling 2015). Therapists followed a cognitive therapy model (Beck and Haigh 2014). 
Clients were offered 14–18 sessions of CBT over a 16–24-week period, each session lasting 
approximately 1 hour.  
 
Trial therapists 
Seventeen DIT therapists saw an average of 4.2 patients (SD = 3.0, range: 1–12). All sessions 
were recorded and up to three sessions per case (M = 2.5, SD = 0.9, range: 1–3), sampled 
from the beginning, middle and end of each treatment, were assessed using the DIT 
 9 
adherence/competence measure (Lemma et al. 2012), rated by the developers (M.T. and 
A.L.) and an expert rater independent of the study. Agreement between the developers and 
the independent rater was high (intraclass correlation coefficient = 0.82).  
Ten PWPs offered LIT, each seeing 5.3 patients on average (SD = 3.0, range: 3–10). 
Their sessions were recorded, but not coded for fidelity, although PWPs received routine 
supervision.  
Thirteen CBT therapists saw an average of 1.54 patients (SD = 0.66, range: 1–3); their 
sessions were recorded and they were routinely supervised. 
 
Outcomes 
The prespecified primary outcome measure was change in mean scores on the 17-item 
version of the HRSD at 6 months indicating full or partial remission (Hamilton 1960), rated 
by research assistants who were blind to treatment allocation. Secondary outcome measures 
included the Beck Depression Inventory-II (BDI; Beck et al. 1996), Brief Symptom 
Inventory (BSI; de Beurs and Zitman 2006), revised Social Adjustment Scale (SAS; 
Weissman et al. 1978), EQ-5D (The EuroQol Group 1990), Experiences in Close 
Relationships Questionnaire-Revised (ECR-R; Fraley et al. 2000) and Inventory of 
Interpersonal Problems-64 (IIP-64; Horowitz et al. 1988).  
 
Statistical analyses 
Therapeutic benefit was assessed by end-point scores and the rate of change on the HRSD-17 
(primary outcome) and BDI-II (secondary outcome) using linear mixed-effects models and 
marginal means. Models included the fixed effects of treatment group (with DIT as the 
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reference group2, e.g., DIT v. LIT and DIT v. CBT), linear time (baseline = 0, 3 months = 1, 6 
months = 2), quadratic time (baseline = 0, 3 months = 1, 6 months = 4), age, sex, ethnicity, 
marital status, higher education status, income bracket, concurrent medical problems, and 
assessment variability (days until assessment relative to the respective assessment period), as 
well as the random effects of patient and time. We tested a random intercept for 
randomization site but this explained almost no variance when covariates were added to the 
model (see Supplement 3 online). Treatment differences between the DIT and LIT/CBT 
groups at the primary end-point (6 months) were evaluated with marginal means and Wald 
chi-square tests.  
All available data post-randomization was used (intention-to-treat analysis). There 
were no missing observations on the HRSD-17 or BDI-II at baseline. However, 24% of 
observations on the HRSD-17 and BDI-II were missing at mid-treatment (3 months), and 
35% at post-treatment (6-months; 57% of missing observations occurred at both mid- and 
post-treatment). Sixty percent of DIT cases were lost to follow-up. Covariates also showed 
small amounts of missing data: higher education status (7%), marital status (5%), ethnicity 
(5%), and income (24%). There were no signs of major bias in the cases showing missing 
values on the outcome measures or covariates, but for completeness we replicated the 
analysis while handling missing data with multiple imputation by chained equations (see 
Supplement 2 online). 
Reliable and clinically significant change on the HRSD-17 and BDI-II was calculated 
using Jacobson and Truax’s (1991) criteria. Specifically, reliable change indices were 
calculated using the sample’s baseline standard deviation on each measure, and reliability 
estimates (Cronbach’s α) from meta-analyses [e.g., HRSD-17 = .79 (Trajkovic et al. 2011); 
                                                 
2 We collapsed the DIT groups over all randomization sites. Sensitivity analyses showed that outcomes did not 
vary by randomization site or study (e.g., pilot trial or feasibility study; see Supplement 3 online). 
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BDI-II = .89 (Erford et al. 2017)]. Reliable improvement (or deterioration) was defined as 
pre–post difference scores >4.81 (or <-4.81) on the HRSD-17, and >7.60 (or <-7.60) on the 
BDI-II. No reliable change was defined as pre–post difference scores between -4.81 and 4.81 
on the HSRD, and between -7.60 and 7.60 on the BDI-II. Validated clinical cut-offs defined 
clinically significant improvement. For instance, baseline HRSD-17 scores >7 or BDI-II 
scores >12 (i.e. mild to severe depression) and 6-month HRSD-17 scores <8 or BDI-II scores 
<13 (i.e. no depression) defined clinically significant improvement (Dozois et al. 1998; 
Zimmerman et al. 2013). The proportion of patients in each treatment group showing reliable 
improvement, deterioration, no reliable change, and clinically significant change was 
compared using logistic regressions while controlling for covariates (age, sex, ethnicity, 
marital status, higher education status, income bracket, concurrent medical problems, and 
end-point assessment variability). Results were also replicated while handling missing data 
with multiple imputation (see Supplement 2 online). 
Additional secondary measures included the ECR-R, BSI, EQ-5D health status 
measure, IIP-64, and SAS. Missing data rates for these measures were non-ignorable (range: 
5–40% at baseline and 34–53% at end of treatment). As the missing values appeared Missing 
At Random (see Supplement 2 online), we applied multiple imputation to handle 
missingness. We imputed and analysed all subscales apart from the child, family, and marital 
subscales of the SAS due to disproportionate amounts of missing data (>70%). Treatment 
differences on each secondary outcome at the primary end-point were evaluated using linear 
regressions on the imputed datasets, with treatment contrast (DIT v. LIT, DIT v. CBT), 
HRSD-17 and BDI-II scores at baseline, age, sex, and end-point assessment variability. To 
ensure that no further bias was introduced by the imputation model, we replicated the 
analyses with the observed data (see Supplement 2 online). 
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Results 
Sample characteristics 
The final sample included 147 patients (39% mild, 47% moderate, and 14% severe on the 
HRSD-17, and 6% mild, 23% moderate, and 71% severe on the BDI-II). Of these, 73 were 
randomized to DIT, 20 to CBT and 54 to LIT, until the end of DIT treatment (minimal 
treatment control). Three percent of observations were discarded because the discrepancy 
between the actual and planned assessment period was too large (greater than a month) to 
assign the observation to a specific time-point.  
Table 1 summarizes demographics for the three groups. They did not differ 
significantly on any demographic variable, but there was a trend towards a difference on the 
percentage of patients with long-term health conditions (e.g. diabetes); therefore, a binary 
variable coding for medical problems was used as covariate in all subsequent analyses. The 
treatment groups showed similar levels of moderate to severe depression at baseline. 
 
Primary Outcome 
Analyses were based on an intent-to-treat sample of 147 patients using all available data. A 
mixed-effects linear regression that included linear and quadratic slopes for time, treatment 
contrast (DIT v. LIT, DIT v. CBT), covariates (age, sex, higher education status, marital 
status, ethnicity, income bracket, co-occurring medical problems, and assessment variability; 
see Supplementary Table 1 for regression coefficients), a random intercept for patient, and 
random linear slope for time, fitted the data well (fixed portion: χ2(17) = 137.71, p < .001; 
random portion: χ2(2) = 81.05, p < .001). Patients varied in their baseline scores (random 
intercept = 7.96, 95% CI [4.85, 12.07]) and amount of change over time (random slope = 
5.49, 95% CI [3.15, 9.57]).  
HRSD-17 scores showed a linear decline over time (b = -3.81, z = -3.11, p = .002, 
 13 
95% CI [-6.21, -1.41]). The rate of change also differed between treatment groups: the LIT 
group showed a stronger quadratic pattern of change compared with the DIT group (b = 2.75, 
z = 2.89, p = .004, 95% CI [0.89, 4.62]). That is, the DIT group showed a steady rate of 
decline over the treatment period, while the LIT group plateaued between the middle and end 
of treatment (Fig. 2). A separate model that included all four assessment points for the DIT 
group only (e.g., baseline, mid-treatment, post-treatment, and follow-up) showed that there 
was no significant difference between marginal HRSD-17 scores at post-treatment and 
follow-up (post-treatment = 10.0 v. follow-up  = 10.7; Wald χ2(1) = 0.28, p = .596, 95% CI [-
2.28, 3.97]). Therefore, the DIT group maintained their gains at follow-up.  
At post-treatment, the DIT group scored significantly lower on the HRSD-17 than the 
LIT group (marginal means: 10.0 v. 14.8; Wald χ2(1) = 8.47, p = .004, 95% CI [1.59, 8.16]; 
marginal d = .70, 95% CI [0.24, 1.16]). There were no significant differences between the 
DIT and CBT groups in end-point marginal means (DIT = 10.0, CBT = 13.2, χ2(1) = 2.80, p 
= .094, 95% CI [-0.56, 7.07]; d = .50, 95% CI [-0.07, 1.07]).  
A logistic regression model with treatment contrast (DIT v. LIT, DIT v. CBT), 
baseline HRSD-17 scores, and covariates (age, sex, higher education status, marital status, 
ethnicity, income bracket, co-occurring medical problems, and end-point assessment 
variability) showed that more DIT patients achieved clinically significant change than LIT 
patients (marginal percentages: 51% v. 9%; χ2(1) = 14.70, p < .001, 95% CI [-.64, -.21]; RR = 
5.17, 95% CI [1.75, 15.25]) and CBT patients (51% v. 20%; χ2(1) = 5.94, p = .01, 95% CI [-
.56, -.06]; RR = 2.55, 95% CI [1.00, 6.54]). All treatment groups showed moderate-to-high 
levels of reliable improvement, moderate levels of no reliable change, and low levels of 
deterioration (see Table 2). Sensitivity analyses demonstrated that the results were maintained 
when (i) multiple imputation was used to handle missing data on the HRSD-17 (see 
Supplement 2 online), (ii) the BDI-II was used as the outcome measure (see Supplement 1 
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online and Supplementary Table 4), and (iii) mild cases were excluded (see Supplement 3 
online). 
 
Secondary outcomes  
We used linear regression models with multiple imputation to examine treatment differences 
on each secondary outcome subscale at post-treatment. Models included treatment group 
(DIT v. LIT, DIT v. CBT), baseline scores on the subscale in question, and the covariates 
listed above. Marginal means at post-treatment are described below and reported in Table 2. 
Marginal means at baseline are presented in Supplementary Table 7 (available online). 
The DIT group reported lower end-point scores on the BSI compared with the LIT 
group, specifically in depression (1.03 v. 1.87; t(141) = 3.58, p = 0.001, 95% CI [0.37, 1.32], 
d  = 0.67, 95% CI [0.30, 1.02]), anxiety (1.00 v. 1.52; t(141) = 2.29, p < .026, 95% CI [0.06, 
0.98], d = .43, 95% CI [0.08, 0.79]), obsessive-compulsiveness (1.26 v. 2.07; t(141) = 3.28, p 
= .002, 95% CI [.31, 1.29], d = .59, 95% CI [.23, .95]), psychoticism (0.77 v. 1.17; t(141) = 
2.42, p = .01, 95% CI [.07, .75], d = .44, 95% CI [.08, .79]), general severity (0.90 v. 1.35; 
t(141) = 2.63, p = .01, 95% CI [0.11, 0.81], d = .49, 95% CI [.13, .84]), and symptom distress 
(1.61 v. 2.13, t(141) = 2.98, p = .005, 95% CI [0.17, 0.88], d = .57, 95% CI [.21, .93]). There 
were no significant differences between the DIT and CBT groups.  
On the SAS, the DIT group reported fewer social problems overall compared with the 
LIT group (2.24 v. 2.50; t(141) = 2.47, p = 0.016, 95% CI [.05, .57], d  = 0.45, 95% CI [.09, 
.81]). Specific improvements were found at work (1.99 v. 2.36; t(141) = 2.66, p = 0.01, 95% 
CI [.09, .65], d  = 0.45, 95% CI [.09, .80]) and with friends (2.39 v. 2.72; t(141) = 2.48, 
p = 0.016, 95% CI [.07, .60], d  = 0.44, 95% CI [.08, 80]) compared with the LIT group.  
Finally, DIT patients reported higher health-related quality of life scores on the EQ-
5D than LIT patients (69.66 v. 60.14; t(141) = -3.02, p = 0.003, 95% CI [-15.81, -3.24], d  = 
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0.55, 95% CI [0.19, 0.90]). Results were replicated using the observed rather than imputed 
data (see Supplementary Table 2). 
 
Therapist fidelity and competence 
Competency ratings were high for all DIT therapists (M = 53.3, SD = 10.6, range: 19–65). All 
therapists were coded as adherent on 80% of recordings (see Supplementary Table 2).  
We explored whether competency ratings predicted treatment outcomes. A mixed-
effects model was used to predict HRSD or BDI-II scores at 6 months from the fixed effects 
of therapist competence (i.e., competence ratings averaged across sessions for the 52 
participants who completed DIT) and covariates (age, sex, education, medical problems, and 
assessment variability at 6 months), and random effects of baseline HRSD (or BDI-II) scores. 
Random effects for therapist and site were not included as they did not significantly improve 
model fit (χ2(2) = 0.013, p > 0.05). Therapist competence did not significantly predict 6-
month HRSD (t(34.81) = 0.483, p > 0.05) or BDI-II (t(23.43) = 0.459, p > 0.05) scores. 
Results were no different when using competence ratings at the initial, mid, or late phases of 
treatment, or when using a log-normal distribution to account for the mild skewness in 
residuals. 
 
Discussion 
This is the first RCT investigating the effect of DIT on moderate to severe depression and the 
first trial of STPP in an IAPT context. Participants randomized to DIT reported significantly 
lower levels of depression following treatment than those who received LIT on both 
clinician-rated (HRSD-17) and self-report (BDI-II) measures. Over half of DIT patients made 
clinically significant improvements, i.e. full recovery, while only 9% of LIT patients 
achieved this. The benefits of DIT were maintained at 12-month follow-up. At post-
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treatment, the DIT group showed reduced overall symptom severity and distress, better social 
adjustment, and fewer health-related problems than the LIT group. Benefits on measures of 
attachment (ECR-R; Fraley et al. 2000) and interpersonal problems (IIP-64) were less 
marked. The findings are nevertheless encouraging as, unlike many other trials of 
psychodynamic psychotherapy (Gerber et al. 2011), this study made use of an active control 
group (LIT) that represents a bona fide form of lower-intensity treatment actually regularly 
provided within the IAPT system by providers who believe in the method.  
These results are consistent with meta-analytic findings that reveal medium or large 
pre–post treatment effects of psychodynamic therapy, with results maintained at longer-term 
follow-up (Abbass et al. 2014; Driessen et al. 2015; Connolly Gibbons et al. 2016). This 
study offers further evidence for STPP in the treatment of depression with moderate severity, 
and confirms that these effects are maintained at least in the short term. The relatively large 
number of trial therapists involved increases confidence in the generalizability of the 
findings. The current trial was not designed to investigate equivalence between STPP and 
CBT, but results suggest that an equivalence trial could be performed. 
The NICE depression guidelines recommend CBT as a first-line psychological 
intervention because of its relatively strong evidence base. This study adds to the evidence 
base for STPP. Recently published data for 2015–2016 show that the vast majority of patients 
were offered CBT and counselling, with DIT offered to only 1% of patients in England (The 
Community Mental Health Team 2016). This may reflect the lack of RCTs supporting the 
specific implementation of dynamic therapy or, more likely, the lack of trained staff able to 
deliver STPP. DIT is unique among the psychodynamic therapies in offering a treatment 
manual and curriculum to enable those without backgrounds in psychodynamic therapies to 
deliver it (Lemma et al. 2017). It is part of a family of dynamic treatments designed to be 
delivered by a broad range of healthcare professionals to optimize accessibility to these 
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approaches (Bateman and Fonagy 2009; Fonagy et al. 2014; Bateman et al. 2016). DIT may 
have a significant role in increasing the general availability of psychodynamic approaches by 
increasing the accessibility of training in this modality. There have been a number of 
different trials of psychodynamic for therapy for depression based on different manuals, but 
DIT attempts to be unique by providing an introduction to psychoanalytic ideas and 
introducing a clinical approach to those with very limited experience of working with these 
models in the hope of making a dynamic approach available at scale. The evaluation of DIT 
training protocols in relation to clinical outcomes is the next hurdle in the dissemination of 
this approach within IAPT. 
This paper also reports a smaller-scale study, which aimed to assess the feasibility of 
an RCT comparing DIT and CBT for depression. Participants readily accepted randomization 
to DIT and CBT, per-protocol treatments and assessments were delivered to almost all 
participants, and 6-month assessments indicated the potential for meaningful comparisons 
between DIT and CBT. No patient, when offered randomization to DIT or CBT refused being 
randomized and once assigned refused to take up the treatment. Although the proportion of 
early terminations was significant (approximately 25% in each group), it was no higher than 
may be expected in routine care at these IAPT sites. Patients found DIT acceptable. 85% of 
the CBT group and 80% of the DIT group were available for assessments at 6 months, 
indicating comparable fidelity to the research protocol. The findings support the feasibility of 
randomizing individuals to either of these high-intensity therapies in the context of routine 
service provision and thus provide the basis for implementing a protocol to test the 
hypothesis that certain patients with major depressive disorder and co-occurring disorders 
may specifically benefit from STPP or CBT. On the basis of this preliminary investigation, 
given the large number of patients with depression currently seen in IAPT, we plan to 
examine the hypothesis that DIT may be considered as a potential alternative to CBT in an 
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adequately powered RCT comparing the two treatments.  
The study has a number of important limitations. The LIT group, while realistic as a 
comparison given the stepped-care protocol implemented in IAPT settings, is not an adequate 
control, as participants may not have had comparable expectations of benefit in the two arms 
of the trial. Participants agreed to randomization to LIT (guided self-help) in the knowledge 
that they would be offered a high-intensity psychological therapy at the end of that treatment 
if they felt they needed it. Many participants did not take up this offer, but the LIT condition 
has features in common with nocebo designs, which may have slightly worse outcomes for 
depressed patients than no-treatment control conditions (Furukawa et al. 2014). Given that 
participants may have perceived the offer of further treatment as contingent on their non-
responsiveness to the LIT intervention, it is possible that the observed impact of DIT was 
exaggerated in this comparison. However, although comparison with the CBT arm was not 
part of the trial design, the lack of a marked difference in the outcomes of the two high-
intensity arms suggests that the superiority of DIT to LIT may be genuine. While adherence 
to the assessment and treatment protocol was relatively good, a substantial proportion of the 
sample failed to complete the additional outcome measures, and multiple imputations were 
needed to provide adequate analysis of the data. Furthermore, 3% of the assessments fell 
outside the pre-specified window and had to be discarded, further reducing the power of 
available contrasts. While the size of the sample for the key comparison of DIT v. LIT was 
adequate, the study is relatively small.  
This study also investigated whether therapist competence was associated with 
outcomes. No evidence of this was found, perhaps because the DIT therapists working in the 
study were all functioning significantly above a minimal level of competence and were 
supervised by the developers. The fact that neither adherence nor competence were examined 
in the CBT pilot group is a further limitation of the study highlighting the need for caution in 
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relation to these findings. 
 
Conclusion 
As IAPT services offer psychodynamic therapy, its efficacy in real-world settings is highly 
relevant to patients, therapists, and the healthcare system. Evidence for the efficacy of 
psychodynamic therapy for common mental disorders is available (Leichsenring et al. 2015), 
but this study is the first to demonstrate DIT’s effectiveness in primary care. Encouraging 
remission rates were obtained, particularly given the severity of the sample and the low 
recovery rate in the LIT condition. Further work is warranted in the IAPT setting to identify 
patient groups for whom DIT may be indicated. We noted informally that referrals to DIT 
were often individuals with adverse childhood experiences, possibly because of the implicit 
belief that DIT may be better at addressing persistent distortions of relationship 
representations, perhaps associated with a history of trauma. This, in turn, in the context of 
large-scale effectiveness studies will require the implementation of DIT at scale in the IAPT 
setting. 
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Table 1. Participant demographics in each treatment group 
Demographic 
Treatment Group  Test values  
LIT (n = 54) DIT (n = 73) CBT (n = 20)  F df  p  
Age (years) 37.2 (10.0) 38.1 (13.0) 38.8 (11.9)  0.160 2, 144 0.853 
        
Assessment time (weeks)        
     3 months 11.8 (2.1) 13.4 (3.4) 12.7 (1.9)  3.8 2, 115 0.025 
     6 months 22.0 (2.0) 26.1 (4.4) 26.3 (3.4)  16.8 2, 109 0.001 
     12 months  62.8 (9.5)      
     2 df p  
n (%) Female 34 (63%) 49 (67%) 14 (70%)  0.406 2 0.816 
        
n (%) Caucasian 31 (61%) 54 (79%) 15 (75%)  5.12 2 0.077 
        
n (%) Married/cohabiting 15 (30%) 22 (32%) 7 (35%)  0.22 2 0.895 
        
Income bracket      0.794 4 0.939 
     <£10,000-20,000 19 (50%) 13 (34%) 6 (16%)     
     £20,000-50,000 24 (41%) 22 (38%) 12 (21%)     
     £50,000-100,000+ 8 (47%) 41 (36%) 3 (18%)     
        
n (%) Completed higher education 27 (55%) 44 (65%) 16 (80%)  3.88 2 0.143 
        
n (%) With medical problems 29 (58%) 37 (67%) 14 (74%)  5.569 2 0.062 
        
HRSD-17 severity     2.814 4 0.589 
     Mild  33% 44% 35%     
     Moderate 48% 45% 55%     
     Severe 19% 11% 10%     
        
BDI-II severity     5.205 4 0.267 
     Mild  6% 3% 15%     
     Moderate 22% 26% 15%     
     Severe 72% 71% 70%     
Note. CBT, cognitive-behavioural therapy; DIT, Dynamic Interpersonal Therapy; LIT, low-intensity therapy; HRSD, Hamilton Rating Scale for Depression-17; BDI-II, Beck 
Depression Inventory-II. Count variables differ in the number of respondents. For continuous measures, values in brackets represent standard deviations. Significant results 
are in bold.  
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Table 2. Marginal means and percentages on the HRSD-17 for each treatment group at each assessment point 
Outcome 
Marginal Estimates (SE)  Contrast [95% CI] 
LIT  DIT  CBT  DIT v. LIT  DIT v. CBT 
Mean Scores          
     Baseline     18.92 (0.70)      18.11 (0.57)      19.14 (1.03)     0.82[–0.94, 2.58]       1.03 [–1.26, 3.32] 
     3 months     14.26 (0.89)      14.17 (0.71)      16.35 (1.24)    0.10 [–2.15, 2.34]       2.18 [–0.62, 4.98] 
     6 months     14.84 (1.39)      9.96 (0.93)      13.22 (1.70)    4.88 [1.60, 8.16]**       3.26 [–0.56, 7.07] 
     12 months           10.70 (1.55)       
          
RCI          
     CSC 9% (0.08)  51% (0.07)  20% (0.11)  -42% [-0.64, -0.21]***  -31% [-0.56, -0.06]* 
     Improvement 42% (0.12)  64% (0.07)  50% (0.15)  -22% [-0.51, 0.07]  -14% [-0.48, 0.19] 
     No Change  56% (0.12)  35% (0.07)  49% (0.15)  20% [-0.08, 0.49]  14% [-0.18, 0.46] 
     Deteriorationa 6% (0.04)  0% (0)  0% (0)  N/A  N/A 
Note. SE, Standard error; CI, confidence interval; LIT, low-intensity therapy; DIT, Dynamic Interpersonal Therapy; CBT, cognitive-behavioural therapy; RCI, Reliable 
Change Indices; CSC, clinically significant change. Outcomes at 12 months were not collected for the LIT and CBT groups.  
a Chi-square difference testing could not be performed due to lack of variation in at least one of the groups estimates. 
Significant results are in bold: * p < 0.05; ** p < 0.01; *** p < 0.001. 
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Table 3. Pro-rated and imputed marginal means and contrasts for the secondary measures at post-treatment  
Outcome measure 
Marginal Mean (SE)  Contrast [95% CI] 
LIT  DIT  CBT  DIT v. LIT  DIT v. CBT 
ECR          
     Avoidance 4.07 (0.17)  4.22 (0.13)  3.80 (0.25)  -0.15 [–0.58, 0.28]  -0.42 [–0.98, 0.13] 
     Anxiety 4.36 (0.16)  4.47 (0.14)  4.21 (0.26)  -0.12 [–0.56, 0.33]  -0.26 [–0.90, 0.37] 
EQ-5D          
     Index 0.79 (0.02)  0.83 (0.01)  0.83 (0.03)  -0.03 [–0.08, 0.01]  0 [–0.06, 0.06] 
     Continuous 60.14 (2.44)  69.66 (2.02)  64.92 (4.05)  -9.52 [-15.81, -3.24]**  -4.75 [–13.83, 4.34] 
BSI          
     Somatic 0.98 (0.16)  0.66 (0.11)  0.77 (0.20)  0.31 [–0.08, 0.70]  0.10 [–0.35, 0.56] 
     OC 2.07 (0.20)  1.26 (0.15)  1.57 (0.27)  0.80 [0.31, 1.29]**  0.31 [–0.32, 0.93] 
     IS 1.68 (0.19)  1.22 (0.16)  1.42 (0.25)  0.46 [–0.03, 0.95]  0.20 [–0.40, 0.80] 
     Depression  1.87 (0.18)  1.03 (0.15)  1.20 (0.25)   0.85 [0.37, 1.32]***  0.18 [–0.40, 0.75] 
     Anxiety 1.52 (0.19)  1.00 (0.13)  0.98 (0.23)  0.52 [0.06, 0.98]*  -0.02 [–0.55, 0.51] 
     Hostility 0.70 (0.14)  0.61 (0.10)  0.70 (0.18)   0.09 [–0.26, 0.44]  0.09 [–0.32, 0.51] 
     Phobic 1.01 (0.19)  0.76 (0.13)  0.59 (0.24)   0.25 [–0.22, 0.72]  -0.17 [–0.71, 0.38] 
     PI 1.10 (0.16)  0.89 (0.12)  1.08 (0.20)   0.22 [–0.19, 0.62]  0.19 [–0.28, 0.66] 
     Psychoticism 1.17 (0.13)  0.77 (0.11)  0.81 (0.17)   0.41 [0.07, 0.75]*  0.05 [–0.36, 0.46] 
     GSI 1.35 (0.14)  0.90 (0.10)  1.01 (0.18)    0.46 [0.11, 0.81]**  0.11 [–0.30, 0.52] 
     PSDI 2.13 (0.14)  1.61 (0.10)  1.73 (0.17)    0.52 [0.17, 0.88]**  0.12 [–0.27, 0.51] 
IIP-64          
     Total distress 1.60 (0.10)  1.46 (0.08)  1.56 (0.14)  0.14 [–0.12, 0.40]  0.10 [–0.22, 0.43] 
     Domineering –0.60 (0.08)  –0.58 (0.07)  –0.60 (0.12)  -0.01 [–0.20, 0.17]  0.00 [–0.27, 0.26] 
     Vindictive –0.40 (0.07)  –0.47 (0.06)  –0.27 (0.10)   0.07 [–0.10, 0.24]   0.19 [–0.04, 0.42] 
     Cold  0.00 (0.09)  –0.14 (0.07)  0.03 (0.12)  -0.04 [–0.07, 0.35]  -0.08 [–0.11, 0.44] 
     Socially Inhibited  0.40 (0.08)  0.32 (0.07)  0.38 (0.12)    0.08 [–0.13, 0.29]  0.06 [0.23, 0.34] 
     Non-assertive  0.53 (0.09)  0.57 (0.07)  0.53 (0.12)  -0.04 [-0.24, 0.16]  -0.04 [–0.33, 0.24] 
     OA 0.23 (0.08)  0.34 (0.06)   0.27 (0.11)  -0.11 [–0.30, 0.08]  -0.07 [–0.32, 0.18] 
     Self-sacrificing 0.24 (0.08)  0.29 (0.07)  0.14 (0.12)  -0.04 [–0.25, 0.16]  -0.15 [–0.42, 0.13] 
     Intrusive –0.40 (0.08)  -0.34 (0.07)  –0.49 (0.11)  -0.06 [–0.26, 0.13]  -0.15 [–0.41, 0.11] 
SAS          
     Total 2.50 (0.08)  2.24 (0.07)  2.50 (0.12)  0.26 [0.05, 0.47]*    0.26 [–0.01, 0.53] 
     Work 2.36 (0.11)  1.99 (0.09)  2.33 (0.17)    0.37 [0.09, 0.65]**    0.35 [-0.04, 0.73] 
     Social (friends) 2.72 (0.11)  2.39 (0.09)  2.50 (0.15)     0.33 [0.07, 0.60]**   0.11 [–0.23, 0.46] 
     Extended family 2.41 (0.10)  2.27 (0.08)  2.58 (0.14)  0.14 [–0.11, 0.39]   0.31 [–0.01, 0.63] 
     Household 2.45 (0.14)  2.26 (0.13)  2.40 (0.21)   0.19 [–0.19, 0.58]   0.14 [–0.37, 0.65] 
Note. SE, Standard error; CI, confidence interval; LIT, low-intensity therapy; DIT, Dynamic Interpersonal Therapy; CBT, cognitive-behavioural therapy; BSI, Brief 
Symptom Inventory; OC, Obsessive-compulsive; IS, Interpersonal sensitivity; PI, Paranoid ideation; GSI, Global Severity Index; PSDI, Positive Symptom Distress Index; 
IIP-64, Inventory of Interpersonal Problems-64; OA; Overly Accommodating; SAS, Social Adjustment Scale. Significant results are in bold: * p < 0.05; ** p < 0.01; 
*** p < 0.001. 
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Fig. 1. CONSORT diagram. 
 
Fig. 2. Predicted and observed mean scores on the HRSD-17 at baseline, mid-treatment, and 
post-treatment for (a) the DIT and LIT groups, and (b) the DIT and CBT groups. 
 
